Literature DB >> 4085584

Differentiation between malignant and non-malignant pleural effusion.

G Mårtensson, K Pettersson, G Thiringer.   

Abstract

In a prospective study of 334 consecutive patients with chronic pleural effusion 156 or 47% had a malignant etiology. The sensitivity of cytological examination of pleural fluid in detecting malignancies was 43%. Thoracoscopy had a sensitivity of 80% and could reveal malignancy in 37 of 47 patients with malignant effusions and a negative cytology. A malignant etiology must also be suspected when atypical cells are found in the pleural fluid as in our study 16 out of 19 fluid samples with atypical cytology represented malignant effusions. The predictive value for a malignant etiology was estimated for the following variables: sex, size of effusion, colour and eosinophils of pleural fluid, smoking habits and asbestos exposure. The predictive value of each variable was estimated separately, combining two by two and by a logistic regression function to exclude correlation to yet another variable. The single variable with the strongest positive predictability towards malignancy was a bloody fluid. Conversely, more than 30 per cent eosinophils in the fluid had the strongest negative predictability towards malignancy. The ability of our statistical method, a logistic regression function to discriminate between malignant and non-malignant etiology was 79%. The estimated probability of a malignant etiology should influence the choice of invasive procedures and the duration and intensity of follow-up.

Entities:  

Mesh:

Year:  1985        PMID: 4085584

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  6 in total

Review 1.  The role of thoracoscopy in the evaluation and management of pleural effusions.

Authors:  C Boutin; P Astoul; B Seitz
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytology.

Authors:  Matthias Woenckhaus; Ulrike Grepmeier; Bernhard Werner; Christian Schulz; Felix Rockmann; Peter J Wild; Georg Röckelein; Hagen Blaszyk; Marion Schuierer; Ferdinand Hofstaedter; Arndt Hartmann; Wolfgang Dietmaier
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

3.  Pleural fluid analysis of lung cancer vs benign inflammatory disease patients.

Authors:  R Kremer; L A Best; D Savulescu; M Gavish; R M Nagler
Journal:  Br J Cancer       Date:  2010-03-09       Impact factor: 7.640

4.  Does pleural fluid appearance really matter? The relationship between fluid appearance and cytology, cell counts, and chemical laboratory measurements in pleural effusions of patients with cancer.

Authors:  Bulent Ozcakar; Carlos H Martinez; Rodolfo C Morice; Georgie A Eapen; David Ost; Mona G Sarkiss; Hsienchang T Chiu; Carlos A Jimenez
Journal:  J Cardiothorac Surg       Date:  2010-08-18       Impact factor: 1.637

5.  Asbestos pleural effusion: a clinical entity.

Authors:  G Mårtensson; S Hagberg; K Pettersson; G Thiringer
Journal:  Thorax       Date:  1987-09       Impact factor: 9.139

6.  Pleural effusion: Role of pleural fluid cytology, adenosine deaminase level, and pleural biopsy in diagnosis.

Authors:  Biswajit Biswas; Sudershan Kumar Sharma; Rameshwar Singh Negi; Neelam Gupta; Virender Mohan Singh Jaswal; Narsimhalu Niranjan
Journal:  J Cytol       Date:  2016 Jul-Sep       Impact factor: 1.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.